You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews

Article metrics

Article menu
XML
Metabolism
SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews

 

Online download statistics by month:

Online download statistics by month: December 2020 to November 2023

AbstractFullPdf
Dec 2020447426198
Jan 2021236229162
Feb 2021828279
Mar 20219691122
Apr 2021989592
May 20216762134
Jun 20217974135
Jul 2021625880
Aug 2021666071
Sep 2021108103116
Oct 2021141130131
Nov 2021868385
Dec 2021777377
Jan 2022797470
Feb 2022464567
Mar 20221018680
Apr 2022898165
May 2022838686
Jun 20229310195
Jul 2022838450
Aug 2022787481
Sep 202216915647
Oct 202220619480
Nov 202213512761
Dec 202211910136
Jan 20231139941
Feb 202313812938
Mar 202314413633
Apr 202311210039
May 202315214748
Jul 202313612740
Aug 202315413345
Sep 202314013236
Oct 202323623144
Nov 202334933749
Total460043462713